TP53 and cancer: Notably, p53 loss/inactivation occurs in ~50% of all cancers (18), whereas RAS mutations are the second most frequent mutation occurring in ~20% of all cancers (reaching 50% in gastrointestinal and 70% in pancreatic cancers) (19).